Abstract
Targeted genetic engineering of human pluripotent cells is a prerequisite for exploiting their full potential. Such genetic manipulations can be achieved using site-specific nucleases. Here we engineered transcription activator–like effector nucleases (TALENs) for five distinct genomic loci. At all loci tested we obtained human embryonic stem cell (ESC) and induced pluripotent stem cell (iPSC) clones carrying transgenic cassettes solely at the TALEN-specified location. Our data suggest that TALENs employing the specific architectures described here mediate site-specific genome modification in human pluripotent cells with similar efficiency and precision as do zinc-finger nucleases (ZFNs).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CHD7 regulates otic lineage specification and hair cell differentiation in human inner ear organoids
Nature Communications Open Access 17 November 2022
-
Presenilin-1 F105C mutation leads to tau accumulation in human neurons via the Akt/mTORC1 signaling pathway
Cell & Bioscience Open Access 14 August 2022
-
Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy
Molecular Cancer Open Access 11 March 2022
Access options
Subscribe to Journal
Get full journal access for 1 year
$99.00
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Zou, J. et al. Cell Stem Cell 5, 97–110 (2009).
Hockemeyer, D. et al. Nat. Biotechnol. 27, 851–857 (2009).
Hockemeyer, D. & Jaenisch, R. Cold Spring Harb. Symp. Quant. Biol. 75, 201–209 (2010).
Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S. & Gregory, P.D. Nat. Rev. Genet. 11, 636–646 (2010).
Soldner, F. et al. Cell (in the press).
Boch, J. & Bonas, U. Annu. Rev. Phytopathol. 48, 419–436 (2010).
Boch, J. et al. Science 326, 1509–1512 (2009).
Moscou, M.J. & Bogdanove, A.J. Science 326, 1501 (2009).
Miller, J.C. et al. Nat. Biotechnol. 29, 143–148 (2011).
Cermak, T. et al. published online, doi:10.1093/nar/gkr218 (14 April 2011).
Lengner, C.J. et al. Cell 141, 872–883 (2010).
Hockemeyer, D. et al. Cell Stem Cell 3, 346–353 (2008).
Zwaka, T. & Thomson, J. Nat. Biotechnol. 21, 319–321 (2003).
Doyon, Y. et al. Nat. Methods 8, 74–79 (2011).
Zhang, F. et al. Nat. Biotechnol. 29, 149–153 (2011).
Acknowledgements
We thank R. Alagappan, P. Xu, S. Cristea, S. Lam and A. Vincent for expert technical assistance. We thank F. Soldner for helpful discussions on the manuscript. D.H. is a Merck Fellow of the Life Sciences Research Foundation. R.J. was supported by US National Institutes of Health grants R37-CA084198, RO1-CA087869 and RO1-HD045022 and by a grant from the Howard Hughes Medical Institute.
Author information
Authors and Affiliations
Contributions
D.H., H.W. and R.J. designed the targeting experiments and wrote the manuscript. H.W. and D.H. generated donor plasmids. D.H. preformed targeting experiments. S.K., C.S.L. and H.W. assisted with Southern blot analysis. Q.G. analyzed teratomas. J.P.C. and D.H. performed FACS analysis of targeted cells. L.Z. and J.C.M. designed the TALENs, S.J.H. assembled the TALENs, G.J.C. and Y.S. tested the TALENs, and B.Z., J.M.C. and X.M. performed the off-target analysis. D.H., R.J., L.Z., G.J.C., J.C.M., B.Z., X.M. and F.D.U. analyzed the data. E.J.R., P.D.G. and F.D.U. designed and supervised the design of the TALENs and contributed to writing the manuscript.
Corresponding author
Ethics declarations
Competing interests
R.J. is an adviser to Stemgent and a cofounder of Fate Therapeutics. G.J.C., L.Z., Y.S., J.C.M., B.Z., J.M.C., X.M., S.J.H., E.J.R., P.D.G. and F.D.U. are full-time employees of Sangamo BioSciences.
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1–4, Supplementary Notes and Supplementary Figures 1–10 (PDF 8120 kb)
Rights and permissions
About this article
Cite this article
Hockemeyer, D., Wang, H., Kiani, S. et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29, 731–734 (2011). https://doi.org/10.1038/nbt.1927
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1927
This article is cited by
-
Genome editing via non-viral delivery platforms: current progress in personalized cancer therapy
Molecular Cancer (2022)
-
Presenilin-1 F105C mutation leads to tau accumulation in human neurons via the Akt/mTORC1 signaling pathway
Cell & Bioscience (2022)
-
CHD7 regulates otic lineage specification and hair cell differentiation in human inner ear organoids
Nature Communications (2022)
-
GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages
Acta Pharmacologica Sinica (2022)
-
mRNA vaccines: the most recent clinical applications of synthetic mRNA
Archives of Pharmacal Research (2022)